معرفی
William Fraser is a Lecturer at the Pharmaceutical & Clinical Pharmacy Research Group (PCPRG) within the College of Health and Life Sciences at Aston University. He holds academic fellowships including Fellow of the Royal Society of Chemistry (FRSC) and Fellow of the Higher Education Academy (FHEA), as well as Chartered Chemist (CChem) and Chartered Scientist (CSi) statuses. His teaching roles include module leadership for Drug Discovery (PHM202) and Principles of Product Analysis and Validation (PHM205) at the Aston Pharmacy School. He also leads educational initiatives such as the Personalisation of Pharmaceuticals (POP) theme and oversees depth assessments for Drugs to Market (DTM) and Inflammation and Immunity (IAI) modules.
Fraser's research focuses on nucleic acid chemistry, heterocyclic compounds, and antimicrobial agents. Key areas include synthetic organic chemistry of nucleosides, drug discovery targeting microbial resistance mechanisms, and DNA triplex formation. His work has produced notable publications on oxadiazoles, oxatriazoles, and pyridine-stretched nucleosides, contributing to advancements in medicinal chemistry and antibacterial agents.
Scientific awards include recognition for his contributions to chemistry education and research. His research trends emphasize organic synthesis methodologies and applications in pharmaceutical development, particularly against pathogens like Clostridioides difficile. Fraser supervises PhD students in drug discovery and has peer-reviewed for journals like Molecules, Arkivoc, and Journal of Heterocyclic Chemistry.
Labs/Teams: Active in the Pharmaceutical & Clinical Pharmacy Research Group (PCPRG), focusing on translational research in drug design and nucleic acid modifications.
